Find clinical trials for Triple Negative Breast Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Phoenix, AZ, USA:
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Chandler, Arizona, United States and 23 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Phoenix, Arizona, United States and 372 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Gilbert, Arizona, United States and 275 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib \[AZD1775\]) in second or third line setting in patients with Triple...
Phase 2
Gilbert, Arizona, United States and 140 other locations
Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 6 other locations
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer...
Phase 3
Chandler, Arizona, United States and 280 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Chandler, Arizona, United States and 310 other locations
The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer...
Phase 1, Phase 2
Gilbert, Arizona, United States and 9 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
Phoenix, Arizona, United States and 65 other locations
to enable the ex vivo generation of CRX100. Patients with non-small cell lung cancer (NSCLC), ovarian cancer, colorectal cancer...
Phase 1
Scottsdale, Arizona, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal